Log inSign up
Henry Han
18.6K posts
Image
user avatar
Henry Han
@HanCardiomd
Cardiologist MBBS, MD, FACC, FESC | Physician-Sci & Researcher MPH | #HeartFailure πŸ§‘β€βš•οΈ| #HFA Committee @escardio | Content Catalyst @TCTMD
USA | Earth 🌎
linktr.ee/hannaung
Joined July 2017
857
Following
16.5K
Followers
  • Pinned
    user avatar
    Henry Han
    @HanCardiomd
    Aug 29, 2025
    What is current guideline-recommended medical therapy for #HFrEF? #ESCCongress @escardio
    Image
    47K
  • user avatar
    Henry Han
    @HanCardiomd
    Aug 20, 2023
    The 2023 ESC Clinical Practice Guidelines πŸ“šCardiomyopathies πŸ“šAcute Coronary Syndromes πŸ“šCardiovascular Disease and Diabetes πŸ“šEndocarditis These new recommendations for you and your patients @escardio #ESCCongress
    Image
    59K
  • user avatar
    Henry Han
    @HanCardiomd
    Jul 1, 2020
    This is one of the best review about MR : A Disease with wide spectrum of therapeutic option in @NatRevCardiol nature.com/articles/s4156… @Ivan_Echocardio @iamritu @purviparwani @PushpaShivaram @EACVIPresident @BonitaEcho @DrHaniMahmoud @fiore_corrado @KemalogluOz @saramoscatelli7
    Image
    Image
    Image
    Image
  • user avatar
    Henry Han
    @HanCardiomd
    Feb 13, 2025
    What's new in heart failure? Jan 2025 #EJHF @ESC_Journals @EJHFEiC @escardio
    Image
    Image
    29K
  • user avatar
    Henry Han
    @HanCardiomd
    Aug 24, 2022
    Unexpectedly met with Prof Fuster at the boarding gate at JFK airport. Same flight to Barcelona ❀️. #ESCCongress
    Image
  • user avatar
    Henry Han
    @HanCardiomd
    Jun 23, 2023
    SGLT2i for Chronic Heart Failure: The Ultimate Solution? onlinelibrary.wiley.com/doi/abs/10.100… #HeartFailure #SGLT2i #CardioEd @ESC_Journals @HFA_President
    Image
    28K
  • user avatar
    Henry Han
    @HanCardiomd
    Sep 7, 2023
    Mechanisms of benefits of #SGLT2i in #HFpEF and the Multifaceted Benefits of SGLT2i πŸ“ŒRegulation of blood sugar, blood pressure, and kidney disease progression. πŸ“ŒInduction of nutrient-deprivation responses leading to increased ketosis and erythropoietin. πŸ“ŒImprovement in
    Image
    Image
    Image
    Image
    48K
  • user avatar
    Henry Han
    @HanCardiomd
    Sep 5, 2022
    #HFpEF as an #Exercise Deficiency Syndrome πŸ“ŒA chronic lack of exercise is a risk factor for HFpEF in certain individuals #JACC #HeartFailure #CardioTwitter @JACCJournals @kovacic_jason @VictorChangInst @SinaiHeartBlood @HFpEF @DrMarthaGulati @AndrewJSauer @SSharmacardio
    Image
    Image
    Image
    Image
  • user avatar
    Henry Han
    @HanCardiomd
    Apr 1, 2022
    πŸ”₯New Recommendation of HFpEF from 2022 AHA/ACC/HFSA Guideline for the Management of #HeartFailure #ACC22 New recommendations for #HFpEF are ; #SGLT2i (Class 2a) #MRAs (Class 2b) #ARNi (Class 2b) #ARB (Class 2b) Routine use of nitrates or #PDE-5 inhibitors (Class 3:No Benefit)
  • user avatar
    Henry Han
    @HanCardiomd
    Jan 15, 2021
    Heart failure drug treatment: the fantastic four #HF #HFrEF #CardioTwitter #MedTwitter We do have 4 standard drugs to offer to our patients as default strategy with remarkable ⬆️ of survival , ⬇️ πŸ₯ rates, ⬇️symptoms, ⬆️quality of life academic.oup.com/eurheartj/adva… @ESC_Journals
    Image
  • user avatar
    Henry Han
    @HanCardiomd
    Mar 2, 2023
    In patients with #HFrEF, quadruple therapy with #ARNI, #BB, #MRA, and #SGLT2i has the potential to increase lifespan 2 to 3 years when used instead of historic double or triple drug regimens Mean Projected Survival: πŸ’ŠQuadruple Therapy - 10.99 years (9.64-12.24) πŸ’ŠTriple
    Image
    Image
    Image
    Image
    61K
  • user avatar
    Henry Han
    @HanCardiomd
    Apr 9, 2022
    Prophylactic #Rivaroxaban Therapy for LV Thrombus After Anterior #STEMI This study supports the short-duration addition of low-dose rivaroxaban (2.5 mg BD ) to #DAPT to prevent LVT formation in patients with anterior STEMI who had undergone #PCI jacc.org/doi/10.1016/j.…
    Image
    Image
    Image
  • user avatar
    Henry Han
    @HanCardiomd
    Nov 5, 2024
    Editorial by #EugeneBraunwald : Advances in the treatment of #HCM Timeline for hypertrophic cardiomyopathy (HCM) treatment and future directions academic.oup.com/eurheartj/adva… @ESC_Journals #EHJ
    Image
    30K
  • user avatar
    Henry Han
    @HanCardiomd
    Mar 4, 2025
    Clinical management and therapeutic optimization of patients with #HFrEF and low blood pressure. A clinical consensus statement of the Heart Failure Association (#HFA) of the @escardio onlinelibrary.wiley.com/doi/epdf/10.10… @ESC_Journals @EJHFEiC
    Image
    Image
    Image
    21K

New to X?

Sign up now to get your own personalized timeline!

Create account

By signing up, you agree to the Terms of Service and Privacy Policy, including Cookie Use.

Terms of Service|Privacy Policy|Cookie Policy|Accessibility|Ads info|Β© 2026 X Corp.
Don't miss what's happening
People on X are the first to know.
Log inSign up
Advertisement
Advertisement